Over the past year, global public health has undergone profound change. Funding has tightened, longstanding partnerships are shifting, and the roles of donors, technical experts, and national governments continue to evolve. In moments like these, it is worth celebrating how The Task Force for Global Health programs confronted complex public health problems and what made their efforts succeed.
In this Fiscal Year 2025 annual report, we will take you on a journey to moments where we faced a problem, took coordinated action with partners, and solved problems in ways never before imagined. Â
Before The Task Force for Global Health existed in its current form, it was founded as The Task Force for Child Survival. Our sole purpose was to improve global childhood immunization rates for vaccine-preventable diseases. Within just six years, global childhood immunization rates quadrupled from 20% to 80%. The Task Force and its partners played a key role in this historic achievement, helping ensure that 80% of children received at least one vaccine to protect against a vaccine-preventable disease. This significant progress contributed to major improvements in childhood survival rates worldwide. Â
This successful coalition established The Task Force as a trusted partner and convener, leading to new opportunities to reduce preventable deaths and disabilities — mobilizing action to eliminate neglected tropical diseases and hepatitis, advancing global polio eradication, and facilitating worldwide distribution of donated medications.
Now, more than 40 years after our founding, The Task Force works in nearly 140 countries, and serves as the secretariat for 16 coalitions, committees, networks, and partnerships. All of our work is united by a vision of communities free from diseases, self-sustaining health systems, and countries continuing to strengthen their capacity to detect and control outbreaks.
To address and mitigate the health risks of today and tomorrow, we must understand the before and after of every situation and story. This year’s annual report celebrates the detections, diagnoses, and decisions made along the journey to achieve success and offers inspiration to those seeking to innovate and reimagine public health systems all over the world.Â
A Personal Note
In the 2025 Fiscal Year, we confronted significant funding and policy challenges and, remarkably, emerged with even more innovation and hope.Â
Our mission – to address the world’s most serious and pressing threats to global health and strengthen the systems that protect and promote health – is built on the pillars of capacity-building and sustainability. This commitment led to significant achievements this past year in empowering countries to address their global health challenges more effectively. From neglected tropical diseases to health security and beyond, The Task Force supported countries implementing and institutionalizing lasting solutions based on their own health priorities. For example, working in partnership with the government of Niger, our Mectizan Donation Program contributed to the country’s milestone as the first in sub-Saharan Africa to eliminate the transmission of river blindness.
We are also proud to have expanded our reach to high-mortality regions in South Asia and Africa by welcoming the Child Health and Mortality Prevention Surveillance (CHAMPS) program to The Task Force. This international surveillance network is dedicated to dramatically decreasing child mortality and stillbirths by shielding pregnant mothers and families from the devastating impacts of health threats that jeopardize them and future generations.
As you scroll through our Fiscal Year 2025 milestones, we hope you feel inspired and heartened knowing that your support makes possible the foundation of these life-saving initiatives. Together, we will continue our work with country partners to increase access to life-saving vaccines, eliminate debilitating infectious diseases, and strengthen the public health systems that save lives and prevent the spread of epidemic disease.Â
Thank you for your trust, commitment, and collaboration as we work together toward a safer, healthier world for all.

Kent Alexander, JD
Chair, Board of Directors

Patrick O’Carroll, MD, MPH
President & CEO
Explore our “Before & After” stories.
Click on a tile below to see how we turned global health challenges into sustainable successes.
Before: Diseases threatened indigenous populations in the Amazon Basin
Before: Choking risks threatened children during treatments.
Before: Millions at risk of blindness from a widespread infection.
Before: No systems to protect high-risk adults from deadly flu.
Before: Hundreds of functional hospital beds slated for the landfill.
Before: Manual paperwork delayed life-changing support for infants.
Before: Siloed health campaigns limited impact.
Before: A nation burdened by disfiguring disease and stigma.
Before: Fragmented health data slowed outbreak response.
Our Programs
The Task Force for Global Health has nearly 20 programs that work with partners in nearly 140 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. Hover over each program below to learn more.
Eliminate Diseases
Children Without Worms
Mapping the Path to a Worm-Free Future
International Trachoma Initiative
Eliminating Trachoma for Good
Coalition for Global Hepatitis Elimination
Building a World Free of Hepatitis
Mectizan Donation Program
Breaking the Cycle of Disease
Neglected Tropical Diseases Support Center
Supporting Research for Thousands to Benefit Millions
Polio Eradication Surge Capacity Support
Stopping Polio in Its Tracks
Ensure Access to Vaccines
Brighton Collaboration
Building Trust through Scientific Rigor
Voices for Vaccines
The Power of Vaccine Advocacy
Partnership for International Vaccine Initiatives
The Power of Meeting Partners Where They Are
Polio Antivirals Initiative
Protecting the Vulnerable
Strengthen Health Systems
Child Health and Mortality Prevention Surveillance
Uncovering the Truth to Save Children’s Lives
Integrated Serosurveillance
One Drop of Blood, a History of Health
Public Health Informatics Institute
Modernizing the Backbone of Global Health
Focus Area for Compassion and Ethics
Integrating Heart and Integrity into Health
MedSurplus Alliance
Transforming Surplus into Lifelines
Strengthening Outbreak Notification And Response
Speeding the Response to Global Threats
Health Campaign Effectiveness
The Power of Collective Action
Migration Health Initiative
Health Knowledge Wherever the Journey Leads
Training Programs in Epidemiology and Public Health Interventions Network
Advancing the Global "Disease Detective" Workforce
Where We Work
Hover over the shaded countries on the map below for information about our programs. To sort the map by programs or sectors, click on the filters just above the map. In addition to programs’ country work, the following programs work at a global level: Health Campaign Effectiveness & Focus Area for Compassion and Ethics.
Leadership Team

Patrick O’Carroll, MD, MPH
President & CEO

Ellen Wild, MPH
Chief Operating Officer

Alicia Fry, MD, MPH
Director, Center for Vaccine Excellence

Nancy Knight, MD
Chief Science and Programs Officer

Patrick Lammie, PhD
Director, Neglected Tropical Disease Support Center

Slavomira “Cici” Roberts, MBA, SPHR
Sr. Director of Human Resources
FY 2025 Financials
Revenue
FY 25 Revenue: $113.9 Million
Excluding Contributions In-Kind*
-
Program support: 87%
-
Indirect cost recovery: 9%
-
Other Income: 3%
Source of funding for Program Support
-
Government: 25%
-
Corporation: 17%
-
Foundation: 45%
-
Other: 3%
Expenses
Excluding Contributions In-Kind*
-
Access to Vaccines: 34.4%
-
Neglected Tropical Diseases: 24.5%
-
Health System Strengthening: 24.6%
-
Admin & fundraising: 16.4%
Use of Contributions In-Kind
-
ITI Zithromax: 98%
-
MDP Mectizan®: 2%
Consolidated Financial Report
Consolidated Financial Statement
*Contributions in-kind are donations of medicine to prevent and treat diseases such as trachoma, lymphatic filariasis and onchocerciasis.
Donors & Partners
The Task Force for Global Health is grateful for the generosity of our funding partners and donors. The following individuals, foundations, corporations, government agencies, and nongovernmental organizations contributed $500 or more in FY25 (September 2024 to August 2025).
Foundations, corporations, government agencies, and nongovernmental organizations
Individuals
A-Mark Foundation
Abbott
Abbvie
American Association for the Study of Liver Diseases (AASLD)
ASCENSION
Asklepios BioPharmaceutical
Association of State and Territorial Health Officials
AstraZeneca
Bayer US LLC
Best Solution Company Limited
Biogen
Boehringer Ingelheim
Brother’s Brother Foundation
Cardiovascular Research Consortium LLC
CDC Foundation
Coalition for Epidemic Preparedness & Innovation (CEPI)
Conrad N Hilton Foundation
Council of State and Territorial Epidemiologists
de Beaumont Foundation
Dispensary of Hope
Eisai Co.
Eli Lilly and Company
Emory University
F Three Foundation
Gates Foundation
Genmab
Gilead Sciences
GSK
Global Health Campus
Global Health MD, LLC
Hasso Plattner Foundation
Hobson & Lucas Family Foundation
Imperial College
International Network on Health and Hepatitis in Substance Users
International Organization for Migration
IQVIA
Izumi Foundation
Johnson & Johnson
Kay Family Foundation
LabConnect
Leprosy Research Initiative
Liver Canada
Map International
Medical Bridges
MediShare
MedWishÂ
MedWorks
Merck & Co., Inc.
Minnesota Department of Health
Moneycorp
Morehouse College of Medicine
National Association of Chronic Diseases
National Health Institutes
National Philanthropic Trust
Novartis Foundation
Novo Nordisk
Pan American Health Organization
Pfizer, Inc.
Resolve to Save Lives
River West Meeting Associates
ROCHE Molecular System
Sanofi Espoir Foundation
Siemens Healthineers
Silicon Valley Community Foundation
Society for Clinical Research Sites
SOS International
Thalia and Michael C. Carlos Foundation
The Albert B. Sabin Vaccine Institute
The Carter Center
The Economist
The Global Fund
The John Martin Foundation
The Kinetix Group
The Petunia Foundation
U.K. Foreign, Commonwealth & Development Office
Universite Claude Bernard
University of Bonn
University of Minnesota
University of Sussex
USAID
U.S. Centers for Disease Control and Prevention
U.S. Department of State
Vertex Pharmaceuticals
Virion Therapeutics
Alan Hinman
Alex Malaspina
Andrew and Faye EvansÂ
Andrew Backe
Andrew Johnston
Andrew M. Haywood
Arthur Lavin
Carol Feinberg
Chan Li Chinobi
Charles and Margaret McTier
Charles M. Shackelford
Craig Eugene Zager
Cristian Muntean
Deborah L. Wexler
Dennis Perales
Diane and Kent Alexander
Diane and Kent Peterson
Dorit Rubinstein
Dylan Brock
Edward Baker
Edward S. Stokan
Edwina Payne
Ellen Wild
Geeta Manek
Gregory W. Heath
James Jackson
James Mahoney
James Niewenhuis
James and Juanita Curran
Jane and Wayne Thorpe
Jared Spotkov
John Hardman
John Papanek
Joseph and Leighton Feczko
Karen and Thomas Hansen
Kathryn Stainback
Kimberly Hagen
Kirk and Nancy Knight
Charles Knirsch
Lauren and Evan Orenstein
Karen LebergottÂ
Leighton E. Moss
Judy Monroe
Mark Walberg
Melissa Schneider
Melissa Vigh
Patricia Gee
Patrick O’Carroll
Quince Marcum
Rafael Souza Dib
Raymond Schinazi
Roberta E. Dickinson
Rosemarie Sampson
Samantha Speede
Stanley and Susan Plotkin
Steve Linowes
Susan Burkhardsmeier
Susan Magocsi
Teresa J. Coutre
Teri and Roderick McClure
Alan J. ChunÂ
The Cantlin Family
Timothy and Janice Long
Adam David Valente
The Wilson Underwood FamilyÂ
Thomas M. Harvey
Timothy L. Coleman
Walkitria Alexander
Walter M. and Judith Deriso
William H. Honore Sr